BiotechTube
Home/AviadoBio/Lisa Deschamps
LD

Lisa Deschamps

Chief Executive Officer

AviadoBio

Therapeutic Areas

Neurodegenerative DiseasesOphthalmology

AviadoBio Pipeline

DrugIndicationPhase
AVB-101Frontotemporal Dementia with GRN mutations (FTD-GRN)Phase 1/2
Program(s) for Retinitis PigmentosaRetinal DystrophiesPre-clinical
Program(s) for ALSAmyotrophic Lateral SclerosisPre-clinical
Program(s) for TauopathiesAlzheimer's Disease and other TauopathiesPre-clinical

Leadership Team at AviadoBio

PC
Prof. Chris Shaw
Chief Scientific and Clinical Advisor, Co-Founder
YB
Youn Bok Lee, PhD
Co-Founder
DY
Do Young Lee, PhD
Co-Founder
GF
Graeme Fielder, PhD
Chief Operating Officer
View full AviadoBio profile